Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Cardiovascular Disease
Interventions
DIETARY_SUPPLEMENT

Fish Oil

On Day 1 and Day 15, participants will receive a 2-week supply of study supplements and will be instructed to consume 4 capsules per day. Each capsule contains 1000 mg of fish oil \[620 mg of DHA and 150 mg of EPA\], providing a total daily dosage of 4000 mg of fish oil \[3080 mg of DHA+EPA\].

DIETARY_SUPPLEMENT

Placebo

On Day 1 and Day 15, participants will receive a 2-week supply of study supplements and will be instructed to consume 4 capsules per day. Each capsule contains 1000 mg of olive oil, providing a total daily dosage of 4000 mg of olive oil.

Trial Locations (1)

N1G 0B4

Nutrasource Diagnostics Inc., Guelph

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biodroga Inc.

INDUSTRY

collaborator

University of Guelph

OTHER

lead

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK